Orloff, L.A., Noel, J.E., Stack, B.C., Russell, M.D., Angelos, P., Baek, J.H., et al. (2021) Radiofrequency Ablation and Related Ultrasound-Guided Ablation Technologies for Treatment of Benign and Malignant Thyroid Disease: An International Multidisciplinary Consensus Statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head & Neck, 44, 633-660.
https://doi.org/10.1002/hed.26960

has been cited by the following article:

• TITLE: Predictors of Successful Radiofrequency Ablation of Benign Thyroid Nodules: A Single Centre Analysis

  AUTHORS: Waswa Edgar, Jiangyuan Cheng, Esraa Atef Saad, Mwale Paul, Wu Meng

  KEYWORDS: Predictors, Radiofrequency Ablation, Benign, Thyroid Nodules

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.16 No.1, January 14, 2025

  ABSTRACT: Objective: To assess the predictors of successful inactivation of benign thyroid nodules using radiofrequency ablation (RFA) and the hormonal responses thereafter. Methods: A retrospective study conducted at Zhongnan Hospital of Wuhan University (January 2022 to January 2024) analysed thyroid tumor characteristics using B-mode ultrasound, colour Doppler imaging, and CEUS post-RFA. Thyroid hormone levels were also assessed before RFA and at 1, 3, and 6 months after the procedure. Results: The study involved 72 patients with benign thyroid nodules, comprising 13 males and 59 females, with a mean age of 45.8 ± 12.1 years. Complete inactivation was achieved in 70.8% of nodules, while 29.2% showed partial inactivation. Nodules with complete inactivation exhibited more calcification (p = 0.040), whereas those with partial inactivation demonstrated higher vascularity (p Conclusion: In conclusion, this study found that therapeutic RFA effectively achieves high rates of complete inactivation in benign thyroid nodules, with the degree of inactivation mainly influenced by nodule vascularity and calcifications.